Invention Grant
- Patent Title: Derivation of embryonic stem cells and embryo-derived cells
-
Application No.: US14266114Application Date: 2014-04-30
-
Publication No.: US09617512B2Publication Date: 2017-04-11
- Inventor: Young Gie Chung , Robert P. Lanza , Irina V. Klimanskaya
- Applicant: Ocata Therapeutics, Inc.
- Applicant Address: US MA Marlborough
- Assignee: Astellas Institute for Regenerative Medicine
- Current Assignee: Astellas Institute for Regenerative Medicine
- Current Assignee Address: US MA Marlborough
- Agency: Wolf, Greenfield & Sacks, P.C.
- Main IPC: C12N5/00
- IPC: C12N5/00 ; C12N5/0735 ; C12N5/073 ; C12N15/873 ; A61K35/12

Abstract:
This present invention provides novel methods for deriving embryonic stem cells and embryo-derived cells from an embryo without requiring destruction of the embryo. The invention further provides cells and cell lines derived without embryo destruction, and the use of the cells for therapeutic and research purposes. It also relates to novel methods of establishing and storing an autologous stem cell line prior to implantation of an embryo, e.g., in conjunction with reproductive therapies such as IVF.
Public/Granted literature
- US20140356952A1 DERIVATION OF EMBRYONIC STEM CELLS AND EMBRYO-DERIVED CELLS Public/Granted day:2014-12-04
Information query